.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A multidisciplinary Delphi study developed practical screening signals for pulmonary hypertension in patients with interstitial lung disease. The panel identified a combination of clinical symptoms and signs, CT and other imaging findings, oxygenation measures, BNP or NT-proBNP, and changes in pulmonary function or six-minute walk performance as useful triggers for further evaluation. The value of the paper is its real-world orientation: pulmonary hypertension in ILD can be easy to miss because worsening dyspnoea and exercise limitation may be attributed entirely to parenchymal lung disease. The consensus approach helps clinicians recognize when the clinical trajectory is disproportionate and should prompt focused assessment. For HCPs, the message is not that every patient needs routine invasive testing. Rather, a structured screening pathway can identify patients who warrant echocardiography and, when indicated, right-heart catheterization or specialist referral. This aligns closely with the conference’s session on pulmonary hypertension screening in progressive ILD and with its broader emphasis on using trends over time to detect clinically important change.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A multidisciplinary Delphi study developed practical screening signals for pulmonary hypertension in patients with interstitial lung disease. The panel identified a combination of clinical symptoms and signs, CT and other imaging findings, oxygenation measures, BNP or NT-proBNP, and changes in pulmonary function or six-minute walk performance as useful triggers for further evaluation. The value of the paper is its real-world orientation: pulmonary hypertension in ILD can be easy to miss because worsening dyspnoea and exercise limitation may be attributed entirely to parenchymal lung disease. The consensus approach helps clinicians recognize when the clinical trajectory is disproportionate and should prompt focused assessment. For HCPs, the message is not that every patient needs routine invasive testing. Rather, a structured screening pathway can identify patients who warrant echocardiography and, when indicated, right-heart catheterization or specialist referral. This aligns closely with the conference’s session on pulmonary hypertension screening in progressive ILD and with its broader emphasis on using trends over time to detect clinically important change.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
